74
Views
21
CrossRef citations to date
0
Altmetric
Original Research

Tryptophan catabolism in acute exacerbations of chronic obstructive pulmonary disease

, , , , , , , & show all
Pages 2435-2446 | Published online: 29 Sep 2016

References

  • LozanoRNaghaviMForemanKGlobal and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010Lancet201238098592095212823245604
  • MininoAMXuJKochanekKDDeaths: preliminary data for 2008. National vital statistics reports: from the Centers for Disease Control and Prevention, National Center for Health StatisticsNational Vital Statistics System2010592152
  • SeemungalTADonaldsonGCPaulEABestallJCJeffriesDJWedzichaJAEffect of exacerbation on quality of life in patients with chronic obstructive pulmonary diseaseAm J Respir Crit Care Med19981575 Pt 1141814229603117
  • DonaldsonGCSeemungalTABhowmikAWedzichaJARelationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary diseaseThorax2002571084785212324669
  • Soler-CatalunaJJMartinez-GarciaMARoman SanchezPSalcedoENavarroMOchandoRSevere acute exacerbations and mortality in patients with chronic obstructive pulmonary diseaseThorax2005601192593116055622
  • KannerREAnthonisenNRConnettJELung Health Study Research GLower respiratory illnesses promote FEV(1) decline in current smokers but not ex-smokers with mild chronic obstructive pulmonary disease: results from the lung health studyAm J Respir Crit Care Med2001164335836411500333
  • WoodruffPGAlbertRKBaileyWCRandomized trial of zileuton for treatment of COPD exacerbations requiring hospitalizationCOPD201181212921299475
  • AlbertRKConnettJBaileyWCAzithromycin for prevention of exacerbations of COPDN Engl J Med2011365868969821864166
  • BroecklingCDAfsarFANeumannSBen-HurAPrenniJERAMClust: a novel feature clustering method enables spectral-matching-based annotation for metabolomics dataAnal Chem201486146812681724927477
  • StoreyJDA direct approach to false discovery ratesJ R Soc Stat Soc2002B64479498
  • SharifRParekhTMPiersonKSKuoYFSharmaGPredictors of early readmission among patients 40 to 64 years of age hospitalized for chronic obstructive pulmonary diseaseAnn Am Thorac Soc201411568569424784958
  • MacKenzieCRHeselerKMullerADaubenerWRole of indoleamine 2,3-dioxygenase in antimicrobial defence and immuno-regulation: tryptophan depletion versus production of toxic kynureninesCurr Drug Metab20078323724417430112
  • SuzukiYSudaTAsadaKSerum indoleamine 2,3-dioxygenase activity predicts prognosis of pulmonary tuberculosisClin Vaccine Immunol201219343644222219312
  • SuzukiYSudaTYokomuraKSerum activity of indoleamine 2,3-dioxygenase predicts prognosis of community-acquired pneumoniaJ Infect201163321522221784100
  • TakikawaOBiochemical and medical aspects of the indoleamine 2,3-dioxygenase-initiated L-tryptophan metabolismBiochem Biophys Res Commun20053381121916176799
  • StoneTWStoyNDarlingtonLGAn expanding range of targets for kynurenine metabolites of tryptophanTrends Pharmacol Sci201334213614323123095
  • MoffettJRNamboodiriMATryptophan and the immune responseImmunol Cell Biol200381424726512848846
  • JenabianMAPatelMKemaIDistinct tryptophan catabolism and Th17/Treg balance in HIV progressors and elite controllersPLoS One2013810e7814624147117
  • ManeglierBMalleretBGuilleminGJModulation of indoleamine-2,3-dioxygenase expression and activity by HIV-1 in human macrophagesFundam Clin Pharmacol200923557358119656212
  • PlattenMWickWVan den EyndeBJTryptophan catabolism in cancer: beyond IDO and tryptophan depletionCancer Res201272215435544023090118
  • PrendergastGCImmune escape as a fundamental trait of cancer: focus on IDOOncogene200827283889390018317452
  • EnginABOzkanYFuchsDYardim-AkaydinSIncreased tryptophan degradation in patients with bronchus carcinomaEur J Cancer Care2010196803808
  • BertiniILuchinatCMiniatiMMontiSTenoriLPhenotyping COPD by 1H NMR metabolomics of exhaled breath condensateMetabolomics201410302311
  • UbhiBKChengKKDongJTargeted metabolomics identifies perturbations in amino acid metabolism that sub-classify patients with COPDMol biosyst20128123125313323051772
  • ManeechotesuwanKKasetsinsombatKWongkajornsilpABarnesPJDecreased indoleamine 2,3-dioxygenase activity and IL-10/IL-17A ratio in patients with COPDThorax201368433033723255616
  • KucichUChristnerPLippmannMImmunologic measurement of elastin-derived peptides in human serumAm Rev Respir Dis19831272S28S306830025
  • UbhiBKRileyJHShawPAMetabolic profiling detects biomarkers of protein degradation in COPD patientsEur Respir J201240234535522183483
  • WendtCHNelsestuenGHarveySGulcevMStoneMReillyCPeptides in bronchoalveolar lavage in chronic obstructive pulmonary diseasePloS One2016115e015572427227774